We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,703
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOOM icon
4826
DMC Global
BOOM
$157M
$229K ﹤0.01%
5,096
+3,389
+199% +$131K
HFRO
4827
Highland Opportunities and Income Fund
HFRO
$407M
$229K ﹤0.01%
14,639
-8,224
-36% -$131K
NHC icon
4828
National Healthcare
NHC
$3.38B
$229K ﹤0.01%
3,242
+1,153
+55% +$75.4K
NVAX icon
4829
Novavax
NVAX
$1.31B
$228K ﹤0.01%
8,523
-72,031
-89% -$2.43M
SYNH
4830
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$228K ﹤0.01%
4,882
-2,444
-33% -$101K
PFBI
4831
DELISTED
Premier Financial Bancorp
PFBI
$228K ﹤0.01%
12,246
+3,023
+33% +$52.1K
APPN icon
4832
Appian
APPN
$2.48B
$227K ﹤0.01%
6,291
-426
-6% -$13.2K
UCTT
4833
Ultra Clean Holdings
UCTT
$3.95B
$227K ﹤0.01%
13,713
-9,702
-41% -$170K
TBCH
4834
Turtle Beach Corp
TBCH
$277M
$227K ﹤0.01%
11,169
+9,508
+572% +$120K
NIM icon
4835
Nuveen Select Maturities Municipal Fund
NIM
$117M
$226K ﹤0.01%
23,183
-11,918
-34% -$115K
PGZ
4836
Principal Real Estate Income Fund
PGZ
$68.7M
$226K ﹤0.01%
12,735
+1,075
+9% +$18.3K
JRS icon
4837
Nuveen Real Estate Income Fund
JRS
$246M
$225K ﹤0.01%
22,457
-2,870
-11% -$28K
NORW icon
4838
Global X MSCI Norway ETF
NORW
$86.1M
$225K ﹤0.01%
10,365
+37
+0.4% +$824
VPG icon
4839
Vishay Precision Group
VPG
$914M
$225K ﹤0.01%
5,892
+1,632
+38% +$55.4K
NQP
4840
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
$224K ﹤0.01%
17,766
+2,608
+17% +$32.6K
SUP
4841
DELISTED
Superior Industries International
SUP
$224K ﹤0.01%
12,493
+2,526
+25% +$41.3K
IMMU
4842
DELISTED
Immunomedics Inc
IMMU
$224K ﹤0.01%
9,451
-179,779
-95% -$3.61M
EVI icon
4843
EVI Industries
EVI
$180M
$223K ﹤0.01%
5,526
+267
+5% +$10.3K
FENY icon
4844
Fidelity MSCI Energy Index ETF
FENY
$1.94B
$223K ﹤0.01%
10,498
-3,174
-23% -$65.7K
FXA icon
4845
Invesco CurrencyShares Australian Dollar Trust
FXA
$98M
$223K ﹤0.01%
3,005
+987
+49% +$74.7K
SSO icon
4846
ProShares Ultra S&P500
SSO
$8.41B
$223K ﹤0.01%
+16,056
New +$221K
VRE
4847
CALL
DELISTED
Veris Residential
VRE
$223K ﹤0.01%
+11,000
New +$203K
TARO
4848
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$222K ﹤0.01%
1,918
-4,008
-68% -$440K
NCI
4849
DELISTED
Navigant Consulting, Inc.
NCI
$222K ﹤0.01%
10,009
+6,707
+203% +$153K
XOXO
4850
DELISTED
Xo Group Inc
XOXO
$222K ﹤0.01%
6,920
+6,168
+820% +$172K

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,703 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.